Fig. 5From: Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGERSevere exacerbations, adjusted rate ratio BDP/FF/G versus BDP/FF (pooled analysis) across eosinophil values. Analysed using a negative binomial model including treatment, country, number of exacerbations in the previous year (1 or > 1) and study as fixed effects, and log-time on study as offset. BDP beclometasone dipropionate, FF formoterol fumarate, G glycopyrroniumBack to article page